UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - ferroptosis
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Methods and Compositions for Treating Melanoma (UCLA Case No. 2021-324)
The Graeber Laboratory at UCLA discovered a novel mechanism for treating melanoma using
ferroptosis
, a type of programmed cell death, that shows promise against therapy resistance. BACKGROUND: Melanoma is a highly aggressive skin cancer that spreads throughout the body and can be fatal if left untreated. Therapies for melanoma range from immunotherapy...
Published: 7/10/2024
|
Inventor(s):
Thomas Graeber
Keywords(s):
Cancer
,
ferroptosis
,
Immunotherapy
,
MAPK signaling
,
Melanoma
,
Oncology
,
Skin
,
tumor resistance
Category(s):
Therapeutics > Oncology
,
Therapeutics > Immunology And Immunotherapy
Integrated Molecular and Lipidomic Analysis of Glioma Tumors Identifies Therapeutic Vulnerabilities (UCLA Case No. 2023-210)
UCLA researchers in the Department of Molecular and Medical Pharmacology have uncovered a novel therapeutic target for Glioblastoma leveraging an extensive lipidomic and transcriptomic database. BACKGROUND: Glioblastoma (GBM) is a fast-growing and aggressive brain tumor. The National Brain Tumor Society predicted that over 14,000 people in the United...
Published: 9/25/2024
|
Inventor(s):
David Nathanson
Keywords(s):
Brain cancer
,
Brain Tumor
,
cancer target
,
cell death
,
ferroptosis
,
Glioblastoma
,
lipidomics
Category(s):
Therapeutics > Oncology